Cargando…

Preeclampsia Prevention by Timed Birth at Term

Most preeclampsia occurs at term. There are no effective preventative strategies. We aimed to identify the optimal preeclampsia screening and timing of birth strategy for prevention of term preeclampsia. METHODS: This secondary analysis was of data from a prospective nonintervention cohort study of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Magee, Laura A., Wright, David, Syngelaki, Argyro, von Dadelszen, Peter, Akolekar, Ranjit, Wright, Alan, Nicolaides, Kypros H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112937/ https://www.ncbi.nlm.nih.gov/pubmed/37035913 http://dx.doi.org/10.1161/HYPERTENSIONAHA.122.20565

Ejemplares similares

Maternal Race and Stillbirth: Cohort Study and Systematic Review with Meta-Analysis
por: Arechvo, Anastasija, et al.
Publicado: (2022)

First-Trimester Screening for Gestational Diabetes Mellitus in Twin Pregnancies
por: Buerger, Olga, et al.
Publicado: (2021)

Early Detection of Preeclampsia Using Circulating Small non-coding RNA
por: Yoffe, Liron, et al.
Publicado: (2018)

Integrated Proteomic and Metabolomic prediction of Term Preeclampsia
por: Bahado-Singh, Ray, et al.
Publicado: (2017)

Maternal Plasma RNA in First Trimester Nullipara for the Prediction of Spontaneous Preterm Birth ≤ 32 Weeks: Validation Study
por: Weiner, Carl P., et al.
Publicado: (2023)

Competing Risks Model for Prediction of Small for Gestational Age Neonates and the Role of Second Trimester Soluble Fms-like Tyrosine Kinase-1
por: Nowacka, Urszula, et al.
Publicado: (2021)

Quantitative ELISAs for serum soluble LHCGR and hCG-LHCGR complex: potential diagnostics in first trimester pregnancy screening for stillbirth, Down’s syndrome, preterm delivery and preeclampsia
por: Chambers, Anne E, et al.
Publicado: (2012)

Early Prediction of Preeclampsia
por: Poon, Leona C., et al.
Publicado: (2014)

Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE)
por: O'Gorman, Neil, et al.
Publicado: (2016)

Detection of Embryonic Trisomy 21 in the First Trimester Using Maternal Plasma Cell-Free RNA
por: Weiner, Carl P., et al.
Publicado: (2022)

An expanded role for heterozygous mutations of ABCB4, ABCB11, ATP8B1, ABCC2 and TJP2 in intrahepatic cholestasis of pregnancy
por: Dixon, Peter H., et al.
Publicado: (2017)

COVID-19 and preterm birth
por: Magee, Laura A, et al.
Publicado: (2021)

A Case-Control Study of Maternal Periconceptual and Pregnancy Recreational Drug Use and Fetal Malformation Using Hair Analysis
por: David, Anna L., et al.
Publicado: (2014)

Preventing deaths due to the hypertensive disorders of pregnancy
por: von Dadelszen, Peter, et al.
Publicado: (2016)

Paternally Expressed, Imprinted Insulin-Like Growth Factor-2 in Chorionic Villi Correlates Significantly with Birth Weight
por: Demetriou, Charalambos, et al.
Publicado: (2014)

Epigenetic-Genetic Chromosome Dosage Approach for Fetal Trisomy 21 Detection Using an Autosomal Genetic Reference Marker
por: Tong, Yu K., et al.
Publicado: (2010)

Peripheral blood cell microRNA quantification during the first trimester predicts preeclampsia: Proof of concept
por: Winger, Edward E., et al.
Publicado: (2018)

SARS-CoV-2 and the subsequent development of preeclampsia and preterm birth: evidence of a dose-response relationship supporting causality
por: Lai, Jonathan, et al.
Publicado: (2021)

Assessment of the fullPIERS Risk Prediction Model in Women With Early-Onset Preeclampsia
por: Ukah, U. Vivian, et al.
Publicado: (2018)

Pregnancy Loss Following Amniocentesis or CVS Sampling—Time for a Reassessment of Risk
por: Ogilvie, Caroline, et al.
Publicado: (2014)

Editorial: Approaches to, and the implications of, timing of birth
por: von Dadelszen, Peter, et al.
Publicado: (2023)

Proteomic Biomarkers of Preterm Birth Risk in Women with Polycystic Ovary Syndrome (PCOS): A Systematic Review and Biomarker Database Integration
por: Galazis, Nicolas, et al.
Publicado: (2013)

Placental growth factor for the prognosis of women with preeclampsia (fullPIERS model extension): context matters
por: Ukah, U. Vivian, et al.
Publicado: (2020)

WILL (When to Induce Labour to Limit risk in pregnancy hypertension): a multicentre randomised controlled trial — adaptations to deliver a timing-of-birth trial during the COVID-19 international pandemic
por: Magee, Laura A., et al.
Publicado: (2022)

Timing of delivery in a high-risk obstetric population: a clinical prediction model
por: De Silva, Dane A., et al.
Publicado: (2017)

Toward personalized management of chronic hypertension in pregnancy
por: Magee, Laura A., et al.
Publicado: (2022)

Systematic Identification of Placental Epigenetic Signatures for the Noninvasive Prenatal Detection of Edwards Syndrome
por: Tsui, Dana W. Y., et al.
Publicado: (2010)

Performance of the neoBona test: a new paired‐end massively parallel shotgun sequencing approach for cell‐free DNA‐based aneuploidy screening
por: Cirigliano, V., et al.
Publicado: (2017)

Metformin in Pregnancy Study (MiPS): protocol for a systematic review with individual patient data meta-analysis
por: Mousa, Aya, et al.
Publicado: (2020)

MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP)—implementation of a national guideline in Canada
por: De Silva, Dane A., et al.
Publicado: (2018)

Preterm preeclampsia in relation to country of birth
por: Ray, J G, et al.
Publicado: (2016)

Preeclampsia prevention
por: Santos, Vitorino Modesto
Publicado: (2016)

Prevention of Preeclampsia
por: Bezerra Maia e Holanda Moura, Sammya, et al.
Publicado: (2012)

Effect of COVID-19 on maternal and neonatal services
por: Khalil, Asma, et al.
Publicado: (2021)

COVID-19 booster doses in pregnancy and global vaccine equity
por: Kalafat, Erkan, et al.
Publicado: (2022)

First Trimester Prediction of Adverse Pregnancy Outcomes—Identifying Pregnancies at Risk from as Early as 11–13 Weeks
por: Bouariu, Alexandra, et al.
Publicado: (2022)

Psychological Impact and Women’s Evaluation of the First-Trimester Pre-Eclampsia Screening and Prevention: ASPRE Trial
por: Nikčević, Ana V., et al.
Publicado: (2023)

SARS-CoV-2 vaccination in pregnancy: a unique opportunity for equity
por: Kalafat, Erkan, et al.
Publicado: (2021)

Clinical Comparison of Preterm Birth and Spontaneous Preterm Birth in Severe Preeclampsia
por: Wen, Yanqing, et al.
Publicado: (2022)

Massive Urinary Protein Excretion Associated with Greater Neonatal Risk in Preeclampsia
por: Mateus, Julio, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_h1jnuibum3qn9b15erfv9l5nbt